Jane Street’s Journey Medical DERM Stock Holding History

Jane Street’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.27M	Buy	+320,021	New	+$1.83M	﹤0.01%	4949
2026 Q1	–	Sell	-13,957	Closed	-$108K	–	11832
2025 Q4	$108K	Buy	+13,957	New	+$109K	﹤0.01%	10151
2025 Q2	–	Sell	-18,599	Closed	-$110K	–	9830
2025 Q1	$110K	Buy	+18,599	New	+$91.5K	﹤0.01%	8765
2024 Q1	–	Sell	-27,749	Closed	-$160K	–	9350
2023 Q4	$160K	Buy	+27,749	New	+$124K	﹤0.01%	8360

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PAIM

Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jane Street's DERM Position: Q2 2026 in Review

Jane Street opened a new position in Journey Medical (DERM) in Q2 2026: 320,021 shares worth $2.27M. The stake represents ﹤0.01% of the portfolio and ranks #4949 among its holdings. This is a return to the name: Jane Street previously reported a position in DERM as recently as Q4 2025.

Jane Street first reported a position in DERM in Q4 2023 and has held it in 4 quarters since. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

Jane Street held 320,021 shares of Journey Medical worth $2.27M as of Q2 2026.
Journey Medical was a new Jane Street position in Q2 2026.
Journey Medical made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #4949 holding.
Jane Street first reported a position in Journey Medical in Q4 2023 and has held it in 4 quarters since.
71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.